National Black Family Cancer Awareness Week

Social Media Toolkit for Oncology Center of Excellence Project Community Initiative

Source: U.S. Food and Drug Administration

Categories: Hem/Onc News and Journals, Latest Headlines

Tags: BlackFamCan, breastcancerawarenessmonth, OCEProjectCommunity

Tweets with this article

FDA Oncology

Black women are more likely to be diagnosed and die with aggressive subtypes of breast cancer. This #BreastCancerAwarenessMonth, #OCEProjectCommunity encourages you to keep and make cancer screening appointments while gearing up for 2022, #BlackFamCan. https://t.co/D1mEf5vpOF https://t.co/vgltm73erR

OCE Conversations on Cancer – Cervical Cancer Treatment Innovation: A Collaborative Discussion

Take this survey powered by surveymonkey.com. Create your own surveys for free.

FDA Oncology January 2, 2025

FDA Broad Agency Announcement: Frequently Asked Questions for Oncology

FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers

FDA Oncology January 2, 2025

OCE Oncology News

A monthly newsletter for oncology/hematology fellows, junior faculty and scientists

FDA Oncology January 1, 2025

2025 FDA-AACR Workshop: DPD Deficiency and Weighing Potential Harms

AACR is hosting a workshop with the FDA on January 16, 2025, to discuss the considerations for routine testing of DPD deficiency before treatment with…

FDA Oncology December 31, 2024